The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

A wireless retinal implant called PRIMA is changing that reality by helping blind patients read and recognize faces again.

The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

See the trailer called “Dude, you broke your fu^&ing board again” then find out what happens next by watching the full ...

People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...

EyePoint Pharmaceuticals (EYPT) just shared that its pivotal Phase 3 trial for DURAVYU in wet age-related macular degeneration has passed the second independent safety committee review. This marks a ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...